0
0
Oslo, October 19, 2025 — New research led by neuroscientists at the University of Oslo reveals that male brains tend to shrink more rapidly with age compared to female brains, offering fresh insights into sex differences in brain aging. Published in the Proceedings of the National Academy of Sciences, the study analyzed over 12,000 MRI brain scans from 4,726 cognitively healthy participants aged 17 to 95, each with at least two scans spaced about three years apart, tracking neurological tissue changes over time.
Key findings point to modest but systematic sex differences in brain volume loss during aging. Men demonstrated a greater reduction in volume across a larger number of brain regions, particularly in various parts of the cortex responsible for sensory and cognitive functions. In contrast, women exhibited decline in fewer regions and maintained more cortical thickness as they aged. Crucially, the hippocampus—a brain area critical for memory and heavily impacted in Alzheimer’s disease—showed no sex difference in volume loss except for a slightly faster decline in older women, likely connected to their longer lifespans rather than heightened disease risk.
The study’s co-author, Anne Ravndal, a neuroscientist at the University of Oslo, commented, “If women’s brains declined more rapidly, it could have helped explain their higher Alzheimer’s disease diagnosis rate. But our findings suggest other factors, such as survival differences or susceptibility mechanisms, may better account for why women get Alzheimer’s twice as often as men.” Brain shrinkage, or atrophy, is a normal part of aging, but exaggerated loss can contribute to cognitive decline and neurodegeneration.
Experts emphasize that this study addresses a critical gap in neuroscience research, which historically has shown a stark sex bias; only 5% of neuroscience and psychiatry publications in 2019 accounted for sex as a biological variable. Fiona Kumfor, clinical neuropsychologist at the University of Sydney, explained, “Understanding typical brain aging in both sexes allows us to better interpret pathological changes in diseases like Alzheimer’s.”
Contextualizing brain volume loss, the men in the study showed about a 2.0% annual decline in volume of certain cortical regions versus 1.2% for women — a difference with potential implications for life expectancy and neurological health. However, volume loss varied regionally, and some brain shrinkage may not always signal negative outcomes, as brain remodeling can also occur.
Implications for public health include the importance of sex-specific approaches in aging research, diagnostics, and potentially personalized interventions. Researchers underscore that biological sex influences brain aging pathways, but cognition and disease risk are shaped by multiple, interacting factors including genetics, lifestyle, and environment. The authors caution that further studies are necessary to elucidate how these anatomical differences relate to functional brain changes and disease vulnerability.
Potential limitations include the observational nature of the MRI data and the inability to establish direct causation between brain volume changes and clinical outcomes such as dementia. Some past studies have reported conflicting results regarding sex differences in brain aging, underscoring the complexity of this field. This study’s large, longitudinal design strengthens evidence but highlights the need to explore sex-specific mechanisms in more detail.
For readers, these findings highlight the importance of maintaining brain health throughout life with strategies like physical exercise, cognitive engagement, balanced nutrition, and managing cardiovascular risk factors. Awareness of differing trajectories in brain aging may guide personalized health decisions and underscore the need to support brain research that accounts for sex differences.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References:
